4
Changes in Ownership
BIODESIX INC Filed Acc 0001140361-23-023965
Chief Development Officer sold 1,527 shares at an average $1.57 ($2,396)
- Chief Development Officer acquired 5,054 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pestano Gary Anthony · Chief Development Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-08 | Exercise or conversion : show line 1 in the form | +5,054 | 100,987 | D | ||
| 2023-05-09 | Sale : show line 2 in the form | −1,101 | $1.57 | $1,725 | 99,886 | D |
| 2023-05-10 | Sale : show line 3 in the form | −426 | $1.58 | $671 | 99,460 | D |
| Open-market sales · 1,527 sh · avg $1.57 · $2,396 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-08 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −1,378 | 15,161 | D |
| 2023-05-08 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −3,676 | 3,675 | D |
Loading xslF345X04/form4.xml…